
GHRP-6 is a synthetic hexapeptide that potently stimulates growth hormone secretion through the ghrelin/GHS receptor — and the most hunger-inducing GHRP available. This is not medical advice.
| Parameter |
Detail |
| Dose |
100 mcg per injection |
| Route |
Subcutaneous injection |
| Timing |
Empty stomach; AM, pre-workout, before bed |
| Frequency |
2-3x daily |
| Cycle |
8-16 weeks on, 4-8 weeks off |
| Vial size |
5 mg |
| Reconstitution |
2 mL BAC water (2,500 mcg/mL) |
| Draw amount |
4 units on insulin syringe |
| Storage |
Refrigerate, use within 28 days |
GHRP-6 is not in the standard cheat sheet — this is a community protocol based on research literature and anecdotal reports.
For the full GHRP-6 peptide profile and comparison guides, see our GHRP-6 Complete Guide and GHRH vs GHRP comparison.
Cycling Details
GHRP-6 doesn't require a loading phase. Start at 100 mcg once daily (bedtime) during Week 1 to gauge hunger response, then increase to 100 mcg 2-3x daily for weeks 2-16. Three daily injections provide pulsatile GH release mimicking natural secretion patterns.
Extended GHRP-6 use may lead to pituitary desensitization. The 8-16 week on / 4-8 week off approach helps maintain receptor sensitivity. Always inject on an empty stomach (at least 2 hours after eating) and wait 20-30 minutes before consuming food.
Routes of Administration

Subcutaneous (standard): Lower abdomen or love handles, rotate daily. Volume is small (0.04-0.12 mL). Use 29-31 gauge insulin syringe. GH release begins within 5-15 minutes; hunger within 15-30 minutes.
Oral (studied but less effective): GHRP-6 retains some GH-releasing activity orally, though at significantly lower potency than subcutaneous (Bowers et al., 1995).
Reconstitution Quick Reference
| Vial Size |
BAC Water |
Concentration |
100 mcg Dose |
| 5 mg |
2 mL |
2,500 mcg/mL |
4 units |
Math: 5,000 mcg / 2 mL = 2,500 mcg/mL. 100 mcg / 2,500 = 0.04 mL = 4 units. Swirl gently, refrigerate, use within 28 days.
For step-by-step reconstitution instructions, see the BPC-157 reconstitution guide — same technique applies to all lyophilized peptides.
Where These Numbers Come From
GHRP-6 has more human clinical data than many research peptides, as it was extensively studied in endocrinology research.
GHRP-6 stimulates GH secretion both in vitro and in vivo through phosphatidylinositol turnover in pituitary somatotroph cells (Lei & Bhargava, 1995). Research established that GHRP-6 requires endogenous hypothalamic GHRH for maximal GH stimulation, explaining the synergistic effects when co-administered with GHRH analogs (Pandya et al., 1998).
Beyond GH release, GHRP-6 has demonstrated cardioprotective and cytoprotective properties independent of GH pathways, acting through GH secretagogue receptor-mediated mechanisms (Berlanga-Acosta et al., 2017).
GHRP-6 activates the ghrelin receptor (GHS-R1a), the same receptor stimulated by endogenous ghrelin. Central administration activates appetite centers in the hypothalamus, including orexin-containing neurons (Wren et al., 2001). The 100 mcg per injection dose is considered near the saturation dose — higher amounts don't meaningfully increase per-bolus GH output.
Stacking Protocols
| Stack |
GHRP-6 Dose |
Partner |
Partner Dose |
Purpose |
| CJC-1295 |
100 mcg SC 2-3x/day |
CJC-1295 no DAC |
100 mcg same syringe |
Gold standard GH stack |
| Ipamorelin |
100 mcg SC 2-3x/day |
Ipamorelin |
200-300 mcg |
Broader GHRP receptor engagement |
| MK-677 |
100 mcg SC 2-3x/day |
MK-677 |
20-25 mg oral PM |
Sustained GH via different half-lives |
| BPC-157 + CJC-1295 |
100 mcg SC 2-3x/day |
BPC-157 + CJC-1295 |
250 mcg + 100 mcg |
Bulking: GH + appetite + gut health |
GHRP-6 and GHRH analogs can be combined in the same syringe. Both require empty stomach. Each GHRP has a per-injection ceiling — stacking doesn't bypass individual receptor saturation.
Side Effects & Safety
- Intense hunger — 15-30 minutes post-injection, lasts 30-60 minutes. Most pronounced of all GHRPs
- Water retention — mild, GH-mediated fluid retention in hands/feet
- Cortisol elevation — dose-dependent, more significant than ipamorelin or GHRP-2
- Prolactin elevation — mild at standard doses; more pronounced above 200 mcg
- Blood sugar effects — GH opposes insulin; monitor if diabetic or insulin-resistant
- Pituitary desensitization — prolonged continuous use may reduce receptor sensitivity; cycling prevents this
- Cancer caution — elevated GH/IGF-1 is theoretically concerning; avoid with active malignancy
Frequently Asked Questions
What is the standard GHRP-6 dose?
100 mcg subcutaneous 2-3 times daily on an empty stomach. This is considered near the saturation dose for maximal GH release per injection.
Does GHRP-6 increase hunger?
Yes — significantly. GHRP-6 activates the ghrelin receptor, producing intense hunger 15-30 minutes post-injection. This is the most pronounced appetite effect of any GHRP, making it beneficial for bulking but challenging for cutting.
Should GHRP-6 be taken on an empty stomach?
Yes — fats and carbohydrates blunt the GH response. Wait at least 2 hours after eating, and 20-30 minutes after injection before consuming food.
How does GHRP-6 compare to GHRP-2?
GHRP-6 causes much more hunger. GHRP-2 may produce slightly higher GH output per dose with less appetite stimulation and lower cortisol/prolactin elevation. Choose GHRP-6 if appetite stimulation is desired.
Can GHRP-6 be stacked with CJC-1295?
Yes — this is the standard GH-releasing stack. The combination produces synergistic GH release far exceeding either peptide alone. They can be mixed in the same syringe.
How do I reconstitute GHRP-6?
Add 2 mL bacteriostatic water to a 5 mg vial (2,500 mcg/mL). 100 mcg = 4 units on an insulin syringe. Swirl gently, refrigerate, use within 28 days.
References
| Citation |
Topic |
PMID |
| Lei & Bhargava, Journal of Pharmacology (1995) |
GHRP-6 stimulates PI turnover in pituitary somatotrophs |
7772238 |
| Pandya et al., Journal of Clinical Endocrinology & Metabolism (1998) |
GHRP-6 requires endogenous GHRH for maximal GH stimulation |
9543138 |
| Bowers et al., Journal of Clinical Endocrinology & Metabolism (1995) |
Oral GHRP-6 GH-releasing effect in children |
7581965 |
| Berlanga-Acosta et al., Clinical Medicine Insights: Cardiology (2017) |
GHRPs cytoprotective effects, historical review |
28469491 |
| Wren et al., Endocrinology (2001) |
Central GHRP-6 activates appetite centers and orexin neurons |
11751604 |
For educational and research purposes only. This is not medical advice. GHRP-6 has clinical research data but is not FDA-approved for general use.